Success Metrics

Clinical Success Rate
86.5%

Based on 45 completed trials

Completion Rate
87%(45/52)
Active Trials
11(14%)
Results Posted
51%(23 trials)
Terminated
7(9%)

Phase Distribution

Ph phase_4
1
1%
Ph not_applicable
35
45%
Ph phase_1
9
12%
Ph phase_3
3
4%
Ph early_phase_1
4
5%
Ph phase_2
16
21%

Phase Distribution

13

Early Stage

16

Mid Stage

4

Late Stage

Phase Distribution68 total trials
Early Phase 1First-in-human
4(5.9%)
Phase 1Safety & dosage
9(13.2%)
Phase 2Efficacy & side effects
16(23.5%)
Phase 3Large-scale testing
3(4.4%)
Phase 4Post-market surveillance
1(1.5%)
N/ANon-phased studies
35(51.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.6%

45 of 58 finished

Non-Completion Rate

22.4%

13 ended early

Currently Active

11

trials recruiting

Total Trials

77

all time

Status Distribution
Active(12)
Completed(45)
Terminated(13)
Other(7)

Detailed Status

Completed45
unknown7
Terminated7
Withdrawn6
Recruiting6
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
77
Active
11
Success Rate
86.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (5.9%)
Phase 19 (13.2%)
Phase 216 (23.5%)
Phase 33 (4.4%)
Phase 41 (1.5%)
N/A35 (51.5%)

Trials by Status

unknown79%
withdrawn68%
active_not_recruiting56%
recruiting68%
terminated79%
not_yet_recruiting11%
completed4558%

Recent Activity

Clinical Trials (77)

Showing 20 of 77 trialsScroll for more
NCT06584747Not Applicable

Study of Cerebral Vascular Reserve Using Pharmacological Testing With Acetazolamide: A Non-Inferiority Study of PET Method Compared to Conventional Reference Scintigraphy

Active Not Recruiting
NCT05133440Phase 2

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Completed
NCT06015295Not Applicable

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

Recruiting
NCT02290834Not Applicable

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

Recruiting
NCT07367815Phase 1

Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease

Not Yet Recruiting
NCT06261905Phase 1

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Completed
NCT05289193Phase 2

CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

Active Not Recruiting
NCT05435300

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

Recruiting
NCT06398392Not Applicable

Radiation Dosimetry of the 18 kDa Translocator Protein Ligand [18F]PBR111 in Humans

Completed
NCT00924027Phase 2

A Study of Patients Receiving High-Dose Rate Brachytherapy

Completed
NCT05737615Phase 1

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Withdrawn
NCT05141643Early Phase 1

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

Active Not Recruiting
NCT01892501Not Applicable

Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy

Completed
NCT04871074Phase 2

The Synapse Project

Completed
NCT05012098Phase 2

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

Completed
NCT00001337Phase 2

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Completed
NCT04101968

The GBA Multimodal Study in Parkinson's Disease

Recruiting
NCT04580693

The Impact of Exercise-Induced Cardiac Remodeling on Myocardial Efficiency

Completed
NCT03554473Phase 1

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Completed
NCT01458366Phase 1

Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
77